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Background: Vertebral Fractures (VFs) are associated with bone loss that occurs before menopause but is accelerated
at menopause as a result of sex hormone deficiency.
To determine the association of sex hormones, bone remodeling markers and vitamin D levels with bone mineral
density (BMD) and asymptomatic VFs prevalence using vertebral fracture assessment (VFA) in a cohort of Moroccan
menopausal women.
Methods: This was a cross-sectional study conducted from October 2012 to April 2013 with menopausal women aged
50 years old and over. A total of 207 women who had no previous diagnosis of osteoporosis were enrolled in this
cross-sectional study. Women were recruited prospectively from our laboratory department. VFA images and scans of
the lumbar spine and proximal femur were obtained using a GE Healthcare Lunar Prodigy densitometer. VFs were
defined using a combination of Genant semiquantitative approach and morphometry. Serum levels of estradiol,
dehydroepiandrosterone sulfate, Sex hormone binding globulin, vitamin D, Osteocalcin, Crosslaps, intact parathormone
were measured by Electrochemiluminescent immunoassay technique.
Results: Among the 207 women, 18.3 % (n = 38) had densitometric osteoporosis. On VFA, VFs were detected in 134
(62.3 %), including 96 (44.6 %) grade 1 and 38 (17.6 %) grade 2/3. There was no difference in the plasma levels of sex
steroids, bone remodeling markers and vitamin D in the group of women with VFs (grade 1 and grade 2/3) and without
VFs. The combination of variables that best predicted grade 2/3 VFs included the number of years since menopause and
the lumbar spine T-score.
Conclusion: These data confirm the importance of postmenopausal estrogen and SHBG concentrations in the bone
loss and the pathogenesis of osteoporosis in elderly women, but not in the occurrence of the VFs.
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Vertebral fracture (VF) is a serious consequence of
osteoporosis that is often under-diagnosed due to the
variable clinical presentation and the lack of a gold
standard for its definition [1, 2]. Thus, 75 % of VFs are not
diagnosed clinically due to the absence of specific symp-
toms in some cases and the difficulty in determining the* Correspondence: aissamelmaataoui@yahoo.fr
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unless otherwise stated.cause of these physical symptoms [3]. It has been shown
that both symptomatic and asymptomatic VFs are predic-
tors of future osteoporotic fractures [4], and are associated
with physical deformity, as well as reduced mobility, qual-
ity of life [5, 6], and increased mortality [7, 8]. Also, VFs
are associated with bone loss that occurs before meno-
pause but is accelerated at menopause and is the result of
sex hormone deficiency [9–11]. Among postmenopausal
and elderly women, low estradiol (E2), low testosterone
(T), and high sex hormone binding globulin (SHBG) con-
centrations are associated with a higher risk of hip and
non VFs [12, 13]. Dehydroepiandrosterone (DHEA) andntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
El maataoui et al. BMC Women's Health  (2015) 15:41 Page 2 of 8its sulfate (DHEAS) are the most abundant circulating
steroids. In postmenopausal women during a 15-year
follow-up, data suggest that high serum DHEAS at base-
line is associated with less bone loss at both femoral neck
and lumbar spine and this association diminishes over
time [14].
Several studies have shown that sex steroid deficiency
is associated with bone loss (REF). However, there is
limited data assessing the association between sex hor-
mones and VFs. Thus, the objective of this study was to
determine the association of sex hormones, bone remod-
eling markers and vitamin D levels with bone mineral
density (BMD) and prevalence of asymptomatic VFs




This was a cross-sectional study conducted from October
2012 to April 2013 with menopausal women 50 years old
and over. A total of 207 women aged 50 years and over,
who had no previous diagnosis of osteoporosis were re-
cruited prospectively from our laboratory department.
General exclusion criteria were non-caucasian origin and
diseases, drugs, and other major determinants known to
affect bone metabolism. Thus, we excluded subjects with
gastrectomy, intestinal resection, recent hyperthyroidism
or hyperparathyroidism, recent severe immobilization or
treatment with corticosteroids (more than 3 months). Our
institutional review board approved this study. The proce-
dures of the study were in accordance with the Declar-
ation of Helsinki, and formal ethics committee approval
was obtained for the study (Military Hospital Ethics
Committee). All the participants gave an informed and
written consent. Each subject completed a standardized
questionnaire designed to document putative risk factors
of osteoporosis. History of fractures, lifestyle (alcohol con-
sumption, gymnastics or jogging/walking, smoking) and
diet (milk, yogurt, cheese) habits were also recorded. The
women were asked whether they usually drank milk, cof-
fee, or alcohol, if they ate cheese or yogurt, if they did
gymnastics or jogging/walking, and if they smoked to-
bacco. Menstrual and reproductive histories were assessed:
all patients were menopausal since at least 1 year. Height
and weight were measured in the rheumatology depart-
ment before DXA measurement, in light indoor clothes
without shoes. Body mass index (BMI) was calculated by
dividing weight in kilograms by height in meters squared.
BMD measurement
Bone mineral density was determined by a Lunar Prodigy
Vision DXA system (Lunar Corp., Madison, WI). The
DXA scans were obtained by standard procedures supplied
by the manufacturer for scanning and analysis. All BMDmeasurements were carried out by two experienced techni-
cians. Daily quality control was carried out by measure-
ment of a Lunar phantom. At the time of the study,
phantom measurements showed stable results. The phan-
tom precision expressed as the coefficient of variation per-
centage was 0.08. Patient BMD was measured at the
lumbar spine (anteroposterior projection at L1–L4) and
at the femoral neck. The World Health Organization
(WHO) classification system was applied, defining osteo-
porosis as T-score ≤ −2.5, osteopenia as −2.5 < T-score < −1.
Study participants were categorized by the lowest T-score
of the L1-4 lumbar spine or femoral neck using our refer-
ence values [19]. VFA was classified using the Genant
semi quantitative (SQ) approach in the following manner:
each VFA image was inspected visually by one expert
clinician (AM) to decide whether it contained a fracture in
any of the visualized vertebrae and assigned a grade based
on the Genant SQ scale [5], where grade 1 (mild) fracture
is a reduction in vertebral height of 20–25 %, grade 2
(moderate) a reduction of 26–40 %, and grade 3 (severe) a
reduction of over 40 %.
Biological measurements
All subjects had fasting blood taken in the morning. Sam-
ples were left to clot at room temperature for 30 min and
then centrifuged. Aliquots of the serum supernatant were
frozen and stored at–80 °C and subsequently thawed and
analyzed in one batch. Serum estradiol (E2) (reference
range, 18.4–201 pmol/l), dehydroepiandrosterone sul-
fate (S-DHEA) (reference range, 0,33–4,18 μmol/l), Sex
hormone binding globulin (SHBG) (reference range,
15–70 ng/ml), vitamin D (25(OH)D3) (reference range,
30–80 ng/ml), Osteocalcin (OC) (reference range, 13–
48 μg/l), Crosslaps (β-CTX) (reference range, 0.010–
0.854 ng/ml), intact parathormone (PTHi) (reference
range, 15–65 pg/ml) were measured by electrochemilu-
minescent immunoassay (ECLIA) technique (Cobas
e601, Roche Diagnostics GmBH, Mannheim, Germany).
All the laboratory tests were subject to validation using
National External Quality Assurance Schemes. The free
estradiol index (FEI) was calculated from the ratio of
serum E2 to SHBG.
Statistical analysis
Results are presented as means (SD) and categorical var-
iables are expressed as frequencies. To compare patients
with and without VFs analysis of variance ANOVA was
used. Correlations between continuous variables were
calculated using Pearson correlation coefficients. Poten-
tial risk factors were entered to a stepwise conditional
binary regression analysis and the resulted odds ratios
with 95 % confidence intervals were reported. The level
for significance was taken as P ≤ 0.05. Excel 2007 and
SPSS 15.0 were used for statistical analysis.
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In this cohort of 207 Caucasian women, the mean (SD)
[Range] age was 59.8 (7.6) [50.0–83.0]. Thirty five percent
of the patients (n = 73) had normal BMD while 46.3 %
(n = 96) were osteopenic and 18.3 % (n = 38) osteopor-
otic. On vitamin D status, the mean (SD) [range] serum
vitamin D concentration for all 207 patients was 13.2
(12.9) ng/mL [3.0–116.5].
In these 207 women, 88.4 % of vertebrae from T4–L4
and 99.0 % from T8-L4 were adequately visualized on
VFA. The percentage of vertebrae not visualized at T4,
T5, T6 levels was 42.1 %, 26.9 %, 13.0 % respectively.
VFs grades 2/3 were detected in 38 (17.6 %) of these
women, while grade 1 were identified in 96 (44.6 %)
(Fig. 1).
Comparison between patients without VFs and with
grade 1 and grades 2/3 VFs are presented in table 1.
Women with grade 2/3 VFs were older and had longer
menopause duration. There was no difference in the
plasma levels of sex steroids, bone remodeling markers
and vitamin D between the three groups.
Correlations of BMD with the clinical and biological
parameters
Pearson correlation analysis showed significant negative
correlations between the lumbar spine BMD and the fol-
lowing variables: age, number of parity, years since meno-
pause, OC, β-CTX, SHBG and FEI. There was positive
correlation between lumbar spine BMD and BMI.
The total hip BMD correlated negatively with the fol-
lowing variables: age, number of parity, years since meno-
pause, OC, β-CTX, SHBG, E2, FEI and S-DHEA. TheT4 T5 T6 T7 T8 T9
Grade 2/3 0 0 0 0 8 8
Grade 1 0 0 0 6 17 19

















Fig. 1 VFA-identified fracture distribution (n = 207)total hip BMD correlated positively with BMI and S-
DHEA (Table 2).Correlations of the sex hormones and the SHBG with the
clinical parameters
There were positive correlations between the E2 levels
and BMI and S-DHEA. There was a negative correlation
between E2 and OC. The FEI correlated positively with
BMI and S-DHEA, and negatively with β-CTX and OC
(Table 2).
There were significant negative correlations between
S-DHEA and the following parameters: age, years
since menopause, SHBG, and OC. There were signifi-
cant positive correlations between S-DHEA and E2
and FEI.
There were significant negative correlations between
SHBG and BMI, and S-DHEA.
There were significant positive correlations between
SHBG and the following parameters: age, β-CTX, 25(OH)
D3, years since menopause, and PTHi (Table 2).Comparison between patients according to quartiles of
E2, FEI and SHBG
Comparison of patients according to quartiles of E2 levels
showed that women in the highest quartile had a higher
BMI and a higher level of S-DHEA.
Comparison of patients according to quartiles of FEI
levels showed that women in the highest quartile had a
higher BMI and BMD at the lumbar spine and total hip.
They had also the lower prevalence of osteoporosis and
β-CTX and OC levels.T10 T11 T12 L1 L2 L3 L4
2 9 10 5 3 3 7
19 33 36 29 45 52 58
184 165 163 172 158 148 139
Table 1 Comparison between patients with and without vertebral fractures (n = 207)
Group 0: Women without
vertebral fractures (n = 73)
mean (SD)
Group 1: Women with
grade 1 vertebral fractures
(n = 96) mean (SD)
Group 2: Women with
grade 2 or 3 vertebral









Age (years) 57,57 (5,92) 60,01 (8,12) 63,64 (8,59) <0.001 <0.001 0,11 0,04
Body mass index (kg/m2) 31,15 (15,54) 31,38 (12,85) 30,25 (5,43) 0,8996 1,00 1,00 1,00
Number of parity 4,78 (1,8) 4,71 (2,5) 5,24 (2,6) 0,49 0,99 1,00 0,72
Years since menopause 7,60 (6,93) 9,40 (8,64) 14,86 (10,83) <0.001 <0.001 0,55 0,004
SHBG (ng/ml) 52,46 (27,11) 57,87 (28,33) 58,26 (29,75) 0,4044 0,91 0,65 1,00
β-CTX (ng/ml) 0,43 (0,24) 0,43 (0,24) 0,41 (0,24) 0,9159 1,00 1,00 1,00
PTHi (pg/ml) 41,14 (36,83) 39,21 (31,46) 35,89 (5,82) 0,7166 1,00 1,00 1,00
E2 (pmol/l) 47,49 (43,83) 43,42 (51,07) 41,80 (21,70) 0,7689 1,00 1,00 1,00
FEI (pmol/nmol) 12,11 (11,50) 10,64 (18,29) 9,28 (5,94) 0,6026 0,99 1,00 1,00
S-DHEA (μmol/l) 2,34 (1,24) 1,97 (0,98) 2,08 (1,35) 0,1138 0,78 0,12 1,00
25 (OH)D3 (ng/ml) 13,20 (9,54) 12,21 (8,07) 24,42 (3,96) 0,1495 0,41 1,00 0,16
Osteocalcin (μg/l) 24,21 (13,95) 23,83 (12,83) 23,61 (14,33) 0,9722 1,00 1,00 1,00
Lumbar spine BMD (g/cm2) 0,97 (0,26) 0,98 (0,18) 1,02 (0,15) 0,4367 0,62 1,00 0,91
Lumbar spine T-score -1,29 (1,20) -1,40 (1,55) -1,09 (1,25) 0,5088 1,00 1,00 0,74
Total hip BMD (g/cm2) 0,93 (0,13) 0,93 (0,14) 0,86 (0,42) 0,2162 0,31 1,00 0,34
Total hip BMD T-score -0,79 (1,11) -0,78 (1,20) -0,71 (1,01) 0,9411 1,00 1,00 1,00
Mean ± SD : m (SD) *: <0.05 **: < 0.001. One way analysis of variance+Post hoc test (Bonferroni) BMD bone mineral density, BMI body mass index, E estradiol, FEI
free estrogen index, PTH parathormone (PTH) intact; S-DHEA dehydroepiandrosterone sulphate, SHBG sex hormones binding globulin, T testosterone
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SHBG levels showed that women in the highest quar-
tiles were older with high prevalence of osteoporosis,
and high PTHi, β-CTX levels. They also had a lower
lumbar and total hip BMD (Table 3).Table 2 Correlation between biochemical values and age, BMI and





Number of parity 0,450** -0,029
YSM 0,736** -0,079 0,338**
SHBG (ng/ml) 0,183** -0,248** 0,024 0,148*
β-CTX (ng/ml) 0,021 -0,127 0,076 -0,039 0,252**
PTHi (pg/ml) 0,024 0,022 0,077 0,026 0,156* 0,3
E2 (pmol/l) 0,023 0,307** 0,076 -0,001 -0,016 -0
FEI (pmol/nmol) -0,109 0,391** 0,039 -0,104 -0,614** -0
S-DHEA (μmol/l) -0,234** 0,083 -0,077 -0,147* -0,195** -0
25(OH)D3 (ng/
ml)
-0,043 -0,052 -0,069 0,030 0,155* -0
OC (μg/l) -0,007 -0,099 -0,041 -0,045 0,277** 0,7
LS BMD (g/cm2) -0,242** 0,293** -0,228** -0,303** -0,292** -0
LS T-score -0,244** 0,287** -0,233** -0,299** -0,274** -0
TH BMD (g/cm2) -0,362** 0,420** -0,216** -0,389** -0,385** -0
TH T-score -0,320** 0,410** -0,206** -0,340** -0,362** -0
BMD bone mineral density, BMI body mass index, E estradiol, FEI free estrogen inde
hormones binding globulin, T testosterone, YSM years since menopauseMultiple logistic regression
Significant variables in the univariate analysis were
entred in a stepwise logistic regression analysis for the
presence of grade 2/3 VFs (grade 1 VFs were excluded


















,131 -0,133 0,245** 0,298**
,098 -0,112 0,098 -0,011 0,060
46** 0,314** -0,153* -0,305** -0,203** -0,123
,182** -0,021 0,138* 0,320** 0,027 0,007 -0,153*
,186** -0,012 0,133 0,304** 0,009 0,008 -0,159*
,241** -0,083 0,136* 0,373** 0,160* 0,031 -0,277**
,204** -0,036 0,119 0,337** 0,129 0,011 -0,246**
x, PTH parathormon, S-DHEA dehydroepiandrosterone sulphate, SHBG sex
Table 3 Comparison between patients according to quartiles of E2, FEI and SHBG
E2 Quartile 1 Quartile 2 Quartile 3 Quartile 4 p
S-DHEA (μmol/l) 4.699 5.8 10.246 22.92 0.01
BMI (kg/m2) 28,03 29,33 31,465 35,69 0,009
FEI Quartile 1 Quartile 2 Quartile 3 Quartile 4 p
BMI (kg/m2) 28,035 28,135 32,194 36,094 0,002
β-CTX (pg/ml) 0,4785 0,4713 0,3999 0,3537 0,015
OC (μg/l) 27,87 25,35 22,03 20,81 0,024
Lumbar spine BMD (g/cm2) 0,9331 0,9288 1,0206 1,0633 0,001
T-score lumbar spine −1,83 −1,507 −1,122 −0,757 <0,0001
Total hip BMD (g/cm2) 0,82031 0,898 0,958 0,9937 <0,0001
T-score total hip −1,262 −1004 −0,576 −0,251 <0,0001
Prevalence of osteoporosis (%) 54,28 50 17,39 15,21 0,006
SHBG Quartile 1 Quartile 2 Quartile 3 Quartile 4 p
Age (years) 57,27 59,59 61,81 60,81 0,014
β-CTX (pg/ml) 0,3453 0,4271 0,4633 0,4694 0,023
PTHi (pg/ml) 29,83 49,7 43,84 40,11 0,022
Lumbar spine BMD (g/cm2) 1,0539 10049 0,9827 0,9014 0,02
T-score lumbar spine −0,843 −1,204 −1,435 −1,753 0,045
Total hip BMD (g/cm2) 1,00609 0,93952 0,83704 0,8866 <0,0001
Total hip BMD T-score −0,185 −0,689 −1,072 −1,164 <0,0001
Prevalence of osteoporosis (%) 14,89 22,72 45,94 51,42 0,026
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tures in postmenopausal women over 50 years. The
best model included the number of years since meno-
pause and the lumbar spine T-score (Table 4).
Discussion
Our study showed that women with grade 2/3 VFs were
older and had higher number of years since menopause.
The best model that predicts grade 2/3 VFs comprised
the number of years since menopause and the lumbar
spine T-score. There was no difference in the plasma
levels of sex steroids, bone remodeling markers and
vitamin D.
VFs were indentified using VFA in 134 (62.3 %), in-
cluding 96 (44.6 %) grade 1 and 38 (17.67 %) grade 2/3.
This prevalence of VFs in our population (grade 2/3) is
similar to figures reported in western Caucasian popula-
tion [15]. Prevalence rates varied between 19 % andTable 4 Stepwise logistic regression analysis for the presence of
grade 2/3 vertebral fractures




1,079 1,036 1,123 <0.001
Lumbar spine T-score:
mean (SD)
1,558 1,112 2,184 0,0124 % in elderly women from the Middle East, Europe
and North America [16]. In a Moroccan study VFs grade
2/3 was detected in 25.6 % of women (17.6 % of women
in this study) [17]. The main difference between these
two Moroccan cohorts was the mean age of participants.
Indeed, in the cohort of El Maghraoui et al. the patients
were older (mean age 65 years) and 43 % of women were
osteoporotic [17], whereas in this study, the patients
were younger (mean age 59) with a higher BMI and only
18 % were osteoporotic.
Comparison of patients according to quartiles of E2
levels showed that women in the highest quartile had a
higher BMI and a higher level of S-DHEA. Pearson cor-
relation analysis showed that there were positive correla-
tions between E2 and BMI and S-DHEA. There was a
negative correlation between the E2 and OC. The posi-
tive correlation between E2 and BMI is explained by the
relationship between estrogen levels and aromatisation
of estrogen precursors in fat stores [18]. The positive
association between E2 and S-DHEA, may be related to
the fact that S-DHEA is an inactive adrenal precursor
that is metabolized into active androgens and estrogens
in peripheral tissues.
In contrast to the OFELY study, we did not find any
association between E2 and VFs. This may be due to the
lower mean age of women in our study compared to the
OFELY study (67 years in women with fracture and 64
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with serum levels of E2 and DHEAS in the lowest quar-
tile had an RR of fracture (20 vertebral and 35 peripheral
fractures) of 2.2 (1.2-4.0) and 2.1 (1.2-3.8) respectively
[19]. Findings from the Study of Osteopororic Fracture
(SOF) suggest that women with estradiol levels > 10 pg/
ml averaged only 0.1 % (−0.7 %, 0.5 %) annual hip bone
loss while women with levels below 5 pg/ml averaged
0.8 % (0.3, 1.2) hip bone loss per year [20]. In a large
prospective cohort of 7598 healthy elderly ambulatory
women (EPIDOS study), aged 75 years or more. women
having serum E2 in the highest quartile (i.e., >10 pg/ml)
were protected, with an HR of 0.66 (0.44–0.98) that did
not remain significant after adjustment for weight (HR =
0.71 [0.47–1.06]) [21].
In our study we found a negative correlation between
the SHBG and the BMD at the lumbar spine and the
total hip. And women in the highest quartiles of SHBG
were older with greater prevalence of osteoporosis and
high PTHi and β-CTX levels. But we did not find any
association between SHBG and the prevalence of VFs. In
contrast, several studies have found that high SHBG
levels were associated with the subsequent occurrence of
VFs, even after adjustment for age and body weight, with
odds ratios of about 1.55 [22–24]. Hoppe and al suggest
that the SHBG level may be a marker for the severity of
osteoporosis, because they found in a study of 184 osteo-
porotic women having a mean age of 76 years, that plasma
SHBG levels were associated with the presence of one or
more VFs and with the number of prevalent fractures [25].
In the lowest quartile of the FEI, we have a significant
increase in both OC and β-CTX in comparison to the
highest quartile of SHBG in which only an increase in
OC level was detected. Also, the decrease in BMD at the
lumbar spine is more important at the lowest quartile of
SHBG compared to the highest quartile of SHBG. These
findings support that in addition to its action on bio-
availability of sex hormones, there is a new pathway by
which sex steroids may act on osteoblasts. The sex ster-
oid/SHBG complex binds to the specific SHBG receptor
(SHBG-R), thereby activating the intracellular signal
transduction pathways [26].
Devine et al. have proved that incident fracture was
predicted by the FEI after adjustment for age, weight,
use of topical estrogen, calcium supplementation and
prevalent fracture. The risk of VF increased with de-
creased free estradiol index (HR per SD reduction:
1.63:95 % CI: 0.91–2.92) [27]. However, a later study
indicated that the effect of free estradiol on fracture risk
in women was attenuated when adjusted for testosterone
and SHBG levels and no longer evident when further
adjusted for body mass index [12]. Similarly, a study in a
French population showed that the association of higher
free estradiol with a lower risk of hip fracture was nolonger significant after adjustment for weight [21]. In
addition to estrogen several other factors have been im-
plicated in bone strength, factors such as progesterone
deficiency [28], and polymorphisms of genes of the re-
ceptor activator of NFκB ligand signaling system [29].
Also, the ERα is the predominant subtype in postmeno-
pausal bone specimens [30], and there is evidence that
mice with normal ERα, but non-functional ERβ, have
normal BMD and trabecular structure [31].
DHEA is an inactive adrenal precursor that is metabo-
lized into active androgens and estrogens in peripheral
tissues. We found significant negative correlations be-
tween S-DHEA and age, years since menopause, SHBG,
and OC. Also, we found significant positive correlations
between S-DHEA and E2 and FEI. However, we did not
find any association between the level of S-DHEA and
the prevalence of VFs. The positive association of S-
DHEA to estradiol and free estradiol may be related to
metabolization of S-DHEA into active androgens and
estrogens in peripheral tissues. The negative associations
of DHEA-S to estradiol and free estradiol can be explained
by increasing age of patients. In fact, increasing age is
associated to the decrease in DHEA-S and consequently
the decrease in the levels of androgens and estrogens.
On vitamin D status, the mean ± SD [range] serum
vitamin D concentration for all 207 patients was 13,23 ±
12,96 ng/mL [3,00 -116,50], taking into account that the
study was conducted in winter. Indeed, in a Moroccan
study, Allali and al. found that the main determinants of
hypovitaminosis D were age > 55 years [OR 2.14 (95 %
IC, 1.1-4.1; =0.026)], wearing a veil [OR 2 (95 % IC, 1.1-4;
P = 0.04)], time spent outdoors less than 30 min/day [OR
2.8 (95 % IC: 1.4-5.7; P = 0.003)], and daily calcium intake
less than 700 mg [OR 2.39 (95 % IC.1.2-4.7; P < 0.01)] [32].
On the association between VFs and vitamin D status
the results of previous studies are contradictory. In our
study, there was no difference in the plasma level of vita-
min D in the group of women with and without VFs
(grade 1 and grade 2/3). May be because of the mean
age of the participants in these study was low, and for
younger patients vitamin D status may play a less im-
portant role in fracture risk. Lopes et al. evaluating the
incidence of VFs observed similar results [33] while, in
contrast to our study, other authors observed significant
association with vitamin D insufficiency [34, 35].
Our study has strengths and limitations. All of the DXA
and biochemical measurements were conducted with a
single bone densitometer and a single biochemistry la-
boratory, with very careful quality controls in place. All
the morphometric assessments were made by an experi-
enced investigator. Before diagnosis of fracture, a non-
osteoporotic origin was considered for each deformity.
However, even history of trauma was inquired, we cannot
exclude that some subjects did not report remote traumas.
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the study and in the procedures used to select subjects,
who were all volunteers and ambulatory.
Conclusion
In summary, we have shown that the best model that
predicts grade 2/3 VFs comprised the number of years
since menopause and the BMD of the lumbar spine. VFs
are the consequence of the decrease of bone mass and
bone strength with age and duration of menopause (de-
cline in the concentration of estrogens), this findings
support the view that aging is the pivotal determinant of
bone mass and bone strength [36]. We did not find any
association between sex hormones and the prevalence of
VFs, likely because of the low mean age of the studied
women (59.8 years). However, the decreased levels of
FEI and the increased levels of SHBG were associated
with increased bone turnover markers and low BMD.
These data confirm the important role played by post-
menopausal estrogen deficiency and SHBG concentra-
tions in the pathogenesis of osteoporosis of elderly
women. For VFs, we must take into account other fac-
tors involved in the quality of the bone strength.
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